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Abstract
SUBSTANCE ABUSE AND PSYCHOSOCIAL FACTORS IN THE HEPATITIS C
POPULATION: IDENTIFYING RISK FACTORS IN DISEASE SEVERITY AND
QUALITY OF LIFE
By Jill C. Clarida, M.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctorate of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2005
Major Directors:

Karen Ingersoll, Ph.D., Assistant Professor,
Department of Psychiatry, Internal Medicine, & Psychology
Sandra Gramling, Ph.D., Associate Professor,
Department of Psychology

Hepatitis C is the most common chronic blood-borne infection in the United
States. Research has focused on contributing factors to the development and progression
of liver disease, but few studies have considered nicotine use as a potential prognostic
factor with CHC. Research has commonly found that CHC patients report with a
diminished quality of life. Several factors have been proposed to account for a decrease
in QOL; however, the mechanisms underlying the impairment in QOL have not yet been
elicited. 76 CHC patients completed self-report measures on a variety of psychosocial
variables and biochemical data for determining the patient's liver disease severity was
obtained.
The findings revealed strong support for the deleterious effects of smoking
cigarettes on liver disease symptomatology and it's progression. Smokers endorsed
experiencing significantly more severe symptoms of fatigue, poor appetite, and
headaches. The CHC smokers tended to present with higher scores on the Aspartate
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Arninotransferase to platelet ratio index (APRI). The smokers' mean score is above the
cut-off value of 1.50 that indicates a .88 predictive value for the presence of hepatic
fibrosis. The level of cigarette consumption could also be a factor in the progression of
liver disease. Individuals smolung more than one pack per day tended to report more
severe symptoms of fatigue and a poorer appetite. Heavy smokers presented with an
APRI mean score above the cut-off value of 2.00 that indicates a .93 negative predictive
value for the presence of cirrhosis below the cut-off value.
General active coping moderated the relationship between liver disease severity
and QOL. The results revealed that patients using more avoidant coping reported lower
levels of QOL on the physical and mental component of the SF-36. Tobacco use
moderated the relationship between liver disease severity and QOL. Interestingly,
smokers reported a higher level of QOL compared to nonsmokers when experiencing
more severe liver disease. CHC patients with higher levels of psychological distress
reported lower QOL on both physical and mental functioning. Individuals smolung
marijuana also tended to report lower levels of QOL on mental functioning. Information
garnered from this study is aimed to help slow the progression of advanced liver disease
in CHC patients in addition to improving their QOL.

Introduction
Increasing emphasis is placed on quality of life (QOL) issues in health care
practice and research today. In 1948, the World Health Organization made mention of the
importance of quality of life in defining health as "a state of complete physical, mental,
and social well-being, and not merely the absence of disease or infirmity." Quality of life
assessments have been used to measure changes in physical functioning, mental, and
social health in order to evaluate efficacy, cost effectiveness, and benefits of new
therapies. In recent years, quality of life variables such as physical functioning or the
extent to which health interferes with a variety of activities and mental health, including
general mood and psychological well-being, have become well established as important
outcomes in medical care. This has been especially true in the area of chronic diseases for
which there are no cures. Researchers have demonstrated that the ability to maintain wellbeing in these different domains is essential to higher quality of life for individuals with
chronic illnesses such as cancer and AIDS (Ben-Zur, Gilbar, & Lev, 2001; Schlenk,
Erlen, Dunbar-Jacob et al., 1998).
Chronic hepatitis C (CHC) is one disease that has been receiving significant
attention in quality of life research. Research has found a diminished quality of life
across various stages of liver disease progression in CHC. Individuals with CHC
infection may have specific fears including abandonment, pain, death, and the exposure
of their drug use or unsafe sexual activity. Uncertainties of the outcome of the infection
can lead to anxiety and depression. For substance abusing patients, psychological distress
may lead them to increase substance use or relapse that will most often produce

